Carolina Solis‐Herrera

2.3k total citations · 1 hit paper
38 papers, 1.7k citations indexed

About

Carolina Solis‐Herrera is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Carolina Solis‐Herrera has authored 38 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Surgery and 19 papers in Molecular Biology. Recurrent topics in Carolina Solis‐Herrera's work include Diabetes Treatment and Management (25 papers), Pancreatic function and diabetes (20 papers) and Metabolism, Diabetes, and Cancer (17 papers). Carolina Solis‐Herrera is often cited by papers focused on Diabetes Treatment and Management (25 papers), Pancreatic function and diabetes (20 papers) and Metabolism, Diabetes, and Cancer (17 papers). Carolina Solis‐Herrera collaborates with scholars based in United States, Italy and Denmark. Carolina Solis‐Herrera's co-authors include Curtis Triplitt, Muhammad Abdul‐Ghani, Giuseppe Daniele, Aurora Merovci, Ralph A. DeFronzo, Devjit Tripathy, Juan Xiong, Luke Norton, Eugênio Cersósimo and Roy Eldor and has published in prestigious journals such as Journal of Clinical Investigation, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Carolina Solis‐Herrera

34 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production

2014 635 citations Aurora Merovci, Carolina Solis‐Herrera et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Carolina Solis‐Herrera

Since Specialization

Citations

This map shows the geographic impact of Carolina Solis‐Herrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolina Solis‐Herrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolina Solis‐Herrera more than expected).

Fields of papers citing papers by Carolina Solis‐Herrera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolina Solis‐Herrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolina Solis‐Herrera. The network helps show where Carolina Solis‐Herrera may publish in the future.

Co-authorship network of co-authors of Carolina Solis‐Herrera

This figure shows the co-authorship network connecting the top 25 collaborators of Carolina Solis‐Herrera. A scholar is included among the top collaborators of Carolina Solis‐Herrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolina Solis‐Herrera. Carolina Solis‐Herrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both 2025 ·Journal of the American College of Cardiology ·Rajiv Agarwal, Jennifer B. Green, (unknown), Janet B. McGill, Amy K. Mottl, Masaomi Nangaku, Julio Rosenstock, (unknown), Muthiah Vaduganathan, Carolina Solis‐Herrera, Charlie Scott, Li Li, (unknown), (unknown), Johannes F.E. Mann	0
2	Repeated Withdrawal of a GLPR Agonist Induces Hyperleptinemia and Deteriorates Metabolic Health in Obese Aging UM‐HET3 Mice 2025 ·Aging Cell ·(unknown), (unknown), Natalia Lawrence, Jun Meng, (unknown), Ziying Xu, Xin Li, (unknown), Abha Chaudhary, (unknown), Guannan Li, Carolina Solis‐Herrera, Yi Zhu, Shangang Zhao	0
3	The potential role of finerenone in patients with type 1 diabetes and chronic kidney disease 2024 ·Diabetes Obesity and Metabolism ·(unknown), (unknown), (unknown), Carolina Solis‐Herrera	7
4	Current Risk Management Strategies in Type 2 Diabetes 2024 ·Eugênio Cersósimo, Carolina Solis‐Herrera, Curtis Triplitt	1
5	Effect of Hyperketonemia on Myocardial Function in Patients With Heart Failure and Type 2 Diabetes 2024 ·Diabetes ·Carolina Solis‐Herrera, Yuejuan Qin, Henri Honka, Eugênio Cersósimo, Curtis Triplitt, (unknown), (unknown), Francisca M. Acosta, (unknown), Patricia Iozzo, Peter T. Fox, Geoffrey D. Clarke, Ralph A. DeFronzo	3
6	Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects 2024 ·Diabetes ·(unknown), Devjit Tripathy, Robert Ćhilton, (unknown), Marzieh Salehi, Carolina Solis‐Herrera, Eugênio Cersósimo, Ralph A. DeFronzo	1
7	Non‐steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes 2023 ·Diabetes Obesity and Metabolism ·Carolina Solis‐Herrera, Curtis Triplitt	6
8	Leptin Reduction as a Required Component for Weight Loss 2023 ·Diabetes ·Shangang Zhao, Na Li, Wei Xiong, Guannan Li, Sijia He, Zhuzhen Zhang, Qingzhang Zhu, (unknown), (unknown), Yi Zhu, May-Yun Wang, Xianlin Han, (unknown), Carolina Solis‐Herrera, Christine M. Kusminski, Zhiqiang An, Joel K. Elmquist, Philipp E. Scherer	16
9	Current Understanding of Sodium N-(8-[2-Hydroxylbenzoyl] Amino) Caprylate (SNAC) as an Absorption Enhancer: The Oral Semaglutide Experience 2023 ·Clinical Diabetes ·Carolina Solis‐Herrera, Michael P. Kane, Curtis Triplitt	12
10	Cardioprotective Effects of Pioglitazone in Type 2 Diabetes 2021 ·Diabetes Spectrum ·Devjit Tripathy, Carolina Solis‐Herrera, Robert E. J. Ryder	1
11	Therapeutic Manipulation of Myocardial Metabolism 2021 ·Journal of the American College of Cardiology ·Henri Honka, Carolina Solis‐Herrera, Curtis Triplitt, Luke Norton, Javed Butler, Ralph A. DeFronzo	55
12	Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy 2020 ·Diabetologia ·Giuseppe Daniele, Carolina Solis‐Herrera, Angela Dardano, Andrea Mari, Andrea Tura, (unknown), (unknown), (unknown), Alessandro Saba, Anna Maria Bianchi, (unknown), Maria Francesca Egidi, Muhammad Abdul‐Ghani, Ralph A. DeFronzo, Stefano Del Prato	20
13	Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects 2020 ·Diabetes ·Aurora Merovci, Devjit Tripathy, Xi Chen, (unknown), Muhammad Abdul‐Ghani, Carolina Solis‐Herrera, Amalia Gastaldelli, Ralph A. DeFronzo	23
14	Effect of Dapagliflozin With and Without Acipimox on Insulin Sensitivity and Insulin Secretion in T2DM Males 2016 ·The Journal of Clinical Endocrinology & Metabolism ·Aurora Merovci, Muhammad Abdul‐Ghani, Andrea Mari, Carolina Solis‐Herrera, Juan Xiong, Giuseppe Daniele, Devjit Tripathy, Ralph A. DeFronzo	32
15	Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus 2015 ·Expert Opinion on Pharmacotherapy ·Curtis Triplitt, Carolina Solis‐Herrera, Eugênio Cersósimo, Muhammad Abdul‐Ghani, Ralph A. DeFronzo	23
16	Assessment of Pancreatic β-Cell Function: Review of Methods and Clinical Applications 2014 ·Current Diabetes Reviews ·Eugênio Cersósimo, Carolina Solis‐Herrera, Michael Trautmann, Jaret Malloy, Curtis Triplitt	194
17	Nephropathy in Youth and Young Adults with Type 2 Diabetes 2014 ·Current Diabetes Reports ·Carolina Solis‐Herrera, Curtis Triplitt, Jane Lynch	20
18	Inhibition of renal glucose reabsorption as a novel treatment for diabetes patients 2014 ·Brazilian Journal of Nephrology ·Eugênio Cersósimo, Carolina Solis‐Herrera, Curtis Triplitt	9
19	Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production 2014 ·Journal of Clinical Investigation ·Aurora Merovci, Carolina Solis‐Herrera, Giuseppe Daniele, Roy Eldor, Teresa Vanessa Fiorentino, Devjit Tripathy, Juan Xiong, (unknown), Luke Norton, Muhammad Abdul‐Ghani, Ralph A. DeFronzo	24
20	Prevalence and Heritability of Clusters for Diagnostic Components of Metabolic Syndrome: The Oman Family Study 2008 ·Metabolic Syndrome and Related Disorders ·Juan Carlos López-Alvarenga, Carolina Solis‐Herrera, Jack W. Kent, Deepali Jaju, Sulayma Albarwani, (unknown), M O Hassan, Riad Bayoumi, Anthony G. Comuzzie	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact